DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹276 Cr | ₹-627 Cr | ₹120 Cr | ₹419 Cr | ₹414 Cr |
What is the latest Net Current Assets ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹276 Cr |
| Mar2024 | ₹-627 Cr |
| Mar2023 | ₹120 Cr |
| Mar2022 | ₹419 Cr |
| Mar2021 | ₹414 Cr |
How is Net Current Assets of DISHMAN CARBOGEN AMCIS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹276 Cr | Positive | |
| Mar2024 | ₹-627 Cr | Negative | |
| Mar2023 | ₹120 Cr | -71.36 | |
| Mar2022 | ₹419 Cr | 1.23 | |
| Mar2021 | ₹414 Cr | - | |
Compare Net Current Assets of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,715.0 Cr | -1% | -3.1% | -35.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -1% |
-3.1% |
-35.8% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses